China Resources Double-Crane Pharmaceutical Co.,Ltd.
China Resources Double-Crane Pharmaceutical Co., Ltd., commonly referred to as Double-Crane, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1999, the company has made significant strides in the development and production of a wide range of pharmaceutical products, including traditional Chinese medicine and modern pharmaceuticals. With a strong operational presence across various regions in China, Double-Crane is dedicated to enhancing healthcare through innovative solutions. The company is renowned for its commitment to quality and research, offering unique formulations that cater to diverse medical needs. Notable achievements include its recognition as a leader in the integration of traditional and modern medicinal practices, solidifying its market position as a trusted provider in the healthcare sector.
DitchCarbon Score
How does China Resources Double-Crane Pharmaceutical Co.,Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
China Resources Double-Crane Pharmaceutical Co.,Ltd.'s score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
China Resources Double-Crane Pharmaceutical Co.,Ltd.'s reported carbon emissions
China Resources Double-Crane Pharmaceutical Co., Ltd., headquartered in CN, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a result, the company appears to lack formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). Without available data or commitments, it is challenging to assess their climate impact or sustainability efforts within the pharmaceutical sector. In the context of the industry, many pharmaceutical companies are increasingly focusing on sustainability and carbon reduction strategies, but China Resources Double-Crane Pharmaceutical Co., Ltd. has yet to publicly align with these trends.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
China Resources Double-Crane Pharmaceutical Co.,Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
